doctor pbm glp-1 approval process obesitymedicine #medicare #glp1 #patientaccess #priorauthorization | Joseph Zucchi, PA-C, MPAS Researchers find GLP-1 medications safe

The Global GLP-1 Receptor Agonists Obesity Drugs Market was valued at USD 9.96 Billion in 2024 and is expected to reach USD 33.12 Billion by 2032, growing at a CAGR of 16.20% (2025-2032).

It is equally about industrial policy, regulatory cooperation and long-term pharmaceutical resilience."At the regional level, the African Continental Free Trade Area (AfCFTA) provides an opportunity to strengthen regulatory cooperation and coordinate procurement strategies, ultimately increasing Africa's collective bargaining power."The COVID-19 lesson that risks being forgottenThe COVID-19 pandemic was widely expected to reshape the relationship between intellectual property and public health.In October 2020, South Africa and India proposed a temporary waiver of certain TRIPS obligations covering vaccines, diagnostics and treatments, arguing that existing intellectual property rules could become a barrier to equitable access during a global health emergency.The negotiations that followed demonstrated just how difficult it remains to reconcile commercial interests with public health priorities

Make this healthy stovetop popcorn with heart-healthy oil instead of butter to cut saturated fat and avoid chemicals in microwave bags

Glucagon-like peptide-1 (GLP-1) is an incretin hormone mainly secreted from intestinal L cells in response to nutrient ingestion

Clean & Thoughtful Ingredients Made with carefully sourced ingredients and manufactured following quality standards for dietary supplements

However, many primary care clinicians hesitate to initiate basal insulin due to concerns regarding time or effort needed to educate patients, doubts about patient acceptance or ability to manage titration or injection, or patient fears of hypoglycemia